tamsulosin hydrochloride

The medicine is used in men to relieve symptoms of urinary tract dysfunction associated with benign prostatic hyperplasia. It helps to reduce muscle tension, which facilitates urine flow and voiding.

Form: capsules, hard modified release

ATC: G04CA02

Manufacturer: A. Menarini Manufacturing Logistics and Services S.r.l.

The medicine is used in men for the treatment of mild (non-cancerous) enlargement of the prostate gland. It helps to relieve urinary problems, such as difficulty or a weak urinary stream and more frequent trips to the toilet.

Form: capsules, hard

ATC: G04CA52

Manufacturer: Adamed Pharma S.A. G.L. Pharma GmbH Laboratorios Leon Farma, S.A.

This medicine is used in men to treat symptoms related to mild enlargement of the prostate gland. It helps to facilitate urination, reduces a weak urinary stream, urgency, and frequent urination during the day and night.

Form: tablets, prolonged release

ATC: G04CA02

Manufacturer: Adamed Pharma S.A.

The medicine is used in men to relieve symptoms related to an enlarged prostate (benign prostatic hyperplasia). It helps facilitate urination, reduces a weak urine stream, urgency, and frequent urination during the day and night.

Form: capsules, extended release

ATC: G04CA02

Manufacturer: APL Swift Services (Malta) Ltd.

The medicine is intended for men to treat symptoms associated with benign prostatic hyperplasia. It helps facilitate urination (e.g., in case of a weak stream), reduces bladder urgency, and limits frequent urination during the day and night.

Form: tablets, prolonged release

ATC: G04CA02

Manufacturer: Pharmachemie B.V. Teva Czech Industries s.r.o. Teva Operations Poland Sp. z o.o. Teva Pharma, S.L.U. Teva Pharmaceutical Works Private Limited Company

The medicine is used in men to treat moderate or severe symptoms related to urination and bladder storage, caused by bladder problems and an enlarged prostate (benign prostatic hyperplasia). It is used when treatment with a single drug has not provided sufficient improvement.

Form: tablets, modified release

ATC: G04CA53

Manufacturer: Genericon Pharma Gesellschaft m.b.H., Synthon B.V., Synthon Hispania S.L., Synthon s.r.o.

The medicine is used in men with an enlarged prostate (benign prostatic hyperplasia). It helps relieve urinary problems, such as a weak stream or frequent bathroom visits, and reduces the risk of a complete blockage of urine flow.

Form: capsules, hard

ATC: G04CA52

Manufacturer: Accord Healthcare Polska Sp. z o.o. Galenicum Health, S.L. SAG Manufacturing S.L.U.

It is used in men with benign prostatic hyperplasia (BPH). It helps relieve urinary problems, such as a weak stream or frequent bathroom visits, and reduces the risk of a complete urinary blockage.

Form: capsules, hard

ATC: G04CA52

Manufacturer: Laboratorios Leon Farma, S.A.

It is used in men to relieve symptoms associated with benign prostatic hyperplasia, such as difficulty urinating, dribbling, strong urge to urinate, and frequent urination during the day and night.

Form: capsules, hard modified release

ATC: G04CA02

Manufacturer: Zentiva, joint-stock company

It is used in men to treat symptoms related to mild prostate enlargement, such as difficulty urinating, dribbling, a strong sensation of sudden urgency to urinate, and frequent urination during the day and night.

Form: capsules, extended release, hard

ATC: G04CA02

Manufacturer: Zentiva, joint-stock company

The medicine is used in men to relieve symptoms associated with benign prostatic hyperplasia. It helps with difficulty urinating, dribbling, a strong sensation of sudden urgency to urinate, and frequent urination during the day and at night.

Form: capsules, hard modified release

ATC: G04CA02

Manufacturer: Zentiva, joint-stock company

The medicine is used in men to relieve symptoms associated with benign prostatic hyperplasia. It helps improve urine flow, makes urination easier, and reduces the sudden urge to use the toilet.

Form: tablets, prolonged release

ATC: G04CA02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used in men to treat moderate or severe lower urinary tract symptoms related to urination and bladder emptying. This results from bladder problems and prostate enlargement (benign prostatic hyperplasia).

Form: tablets, modified release

ATC: G04CA53

Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.

It is used in men to treat symptoms associated with benign prostatic hyperplasia. It helps facilitate urination, reduces difficulties with urine flow, and relieves the sensation of sudden urgency and frequent urination.

Form: tablets, prolonged release

ATC: G04CA02

Manufacturer: Genericon Pharma Gesellschaft m.b.H. G.L. Pharma GmbH Synthon B.V. Synthon Hispania S.L.

The medicine is used in men to treat symptoms associated with benign prostatic hyperplasia. It helps facilitate urination, reduces a weak stream, and limits urgency and frequent trips to the toilet.

Form: capsules, modified release

ATC: G04CA02

Manufacturer: Delpharm Meppel B.V.

The medicine is used in men to relieve symptoms related to an enlarged prostate. It helps facilitate urination, reduces a weak urinary stream, bladder urgency, and frequent urination during the day and night.

Form: tablets, film-coated, prolonged release

ATC: G04CA02

Manufacturer: Delpharm Meppel B.V.

The medicine is used to relieve urinary symptoms caused by an enlarged prostate (benign prostatic hyperplasia). It helps to facilitate urination and reduces bladder urgency.

Form: capsules, hard modified release

ATC: G04CA02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

It is used in men to treat symptoms associated with benign prostatic hyperplasia. It helps facilitate urination, improve urine flow, and reduce bladder urgency.

Form: capsules, extended release, hard

ATC: G04CA02

Manufacturer: Gedeon Richter Plc.

It is used in men to relieve symptoms of urinary tract dysfunction associated with benign prostatic hyperplasia. The medicine reduces muscle tension, which facilitates urine flow and voiding.

Form: capsules, hard modified release

ATC: G04CA02

Manufacturer: Quinta-Analytica s.r.o., Synthon B.V., Synthon Hispania S.L.

It is used to relieve symptoms associated with an enlarged prostate (benign prostatic hyperplasia). It helps with difficulties in urination (e.g., weak stream), urgency, and frequent urination during the day and night.

Form: capsules, extended release

ATC: G04CA02

Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.

The medicine is used in men to treat moderate to severe lower urinary tract symptoms. These symptoms may result from bladder problems or prostate enlargement (benign prostatic hyperplasia) and include, among others, difficulty urinating, frequent urgency, or the need to use the toilet more often.

Form: tablets, modified release

ATC: G04CA53

Manufacturer: Adamed Pharma S.A.

It is used to treat symptoms associated with mild prostate enlargement, such as difficulty urinating (weak stream), dribbling, sudden urgency to urinate, and increased frequency of urination during the day and night.

Form: tablets, prolonged release

ATC: G04CA02

Manufacturer: Adamed Pharma S.A.

The medicine is used in men to treat moderate or severe symptoms related to bladder storage and emptying caused by bladder problems and an enlarged prostate (benign prostatic hyperplasia).

Form: tablets, modified release

ATC: G04CA53

Manufacturer: Adamed Pharma S.A.

The medicine is used in men to treat moderate to severe symptoms related to urination and bladder storage. These symptoms result from bladder problems and an enlarged prostate (benign prostatic hyperplasia).

Form: tablets, modified release

ATC: G04CA53

Manufacturer: Adamed Pharma S.A.

It is used to treat symptoms associated with benign prostatic hyperplasia (BPH). It helps to reduce muscle tension, which facilitates urine flow and voiding.

Form: capsules, hard modified release

ATC: G04CA02

Manufacturer: Synthon Hispania S.L.

It is used to treat symptoms associated with benign prostatic hyperplasia, such as difficulty urinating.

Form: capsules, extended release, hard

ATC: G04CA02

Manufacturer: Farmak International Sp. z o.o.

It is used in men to relieve symptoms associated with benign prostatic hyperplasia. It helps facilitate urination, reduces bladder urgency, and alleviates problems such as a weak urinary stream or frequent urination during the day and night.

Form: capsules, extended release, hard

ATC: G04CA02

Manufacturer: Orion Corporation

The medicine is used in men to relieve symptoms associated with benign prostatic hyperplasia. It helps facilitate urine flow and voiding, reduces bladder urgency, and alleviates difficulties such as a weak urinary stream, dribbling, or frequent trips to the toilet (including at night).

Form: tablets, prolonged release

ATC: G04CA02

Manufacturer: Laboratoires Normon S.A. Synthon B.V. Synthon Hispania S.L.

This medicine is used in men to relieve symptoms associated with benign prostatic hyperplasia. It helps with difficulties in urination (e.g., weak stream, dribbling), sudden urgency to urinate, and frequent urination during the day and night.

Form: tablets, prolonged release

ATC: G04CA02

Manufacturer: APL Swift Services (Malta) Ltd. Arrow Génériques Generis Farmacêutica, S.A.

It is used in men to treat moderate to severe bladder and prostate enlargement (benign prostatic hyperplasia) symptoms. It helps, among other things, with problems starting urination, a weak urine stream, frequent urination, and sudden urgency to urinate.

Form: tablets, modified release

ATC: G04CA53

Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.

The medicine is used to relieve symptoms associated with mild enlargement of the prostate gland, such as a weak urinary stream, dribbling, urgency, and frequent urination during the day and night.

Form: capsules, hard modified release

ATC: G04CA

Manufacturer: Lek Pharmaceuticals d.d. Lek Pharmaceuticals d.d. LEK S.A. Rowa Pharmaceuticals Ltd. Salutas Pharma GmbH Salutas Pharma GmbH Synthon B.V. Synthon Hispania S.L.

The medicine is used in men to relieve symptoms related to an enlarged prostate. It helps to reduce the tension in the muscles of the urinary tract, which facilitates urine flow and voiding, and reduces the feeling of bladder urgency.

Form: tablets, prolonged release

ATC: G04CA02

Manufacturer: Genericon Pharma Gesellschaft m.b.H. G.L. Pharma GmbH Industria Quimica y Farmaceutica VIR S.A. Synthon B.V. Synthon Hispania S.L.

The medicine is used in men to relieve symptoms related to an enlarged prostate. It helps facilitate urination, reduces a weak urinary stream, urgency, and frequent urination during the day and night.

Form: capsules, hard modified release

ATC: G04CA02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used in men to treat symptoms associated with benign prostatic hyperplasia (enlarged prostate). It helps to reduce muscle tension, which improves urine flow and makes urination easier.

Form: capsules, hard modified release

ATC: G04CA02

Manufacturer: McDermott Laboratories t/a Gerard Laboratories, Mylan Hungary Ltd., Synthon Hispania S.L.

The medicine is used in men to relieve symptoms associated with benign prostatic enlargement (prostate). It helps facilitate urine flow and reduces the feeling of sudden urgency, which is useful for difficulties in urination or frequent urination during the day and night.

Form: capsules, hard modified release

ATC: G04CA02

Manufacturer: Aristo Pharma GmbH, Laboratorios Medicamentos Internacionales S.A.

The medicine is used in men to relieve symptoms associated with benign prostatic hyperplasia. It helps facilitate urination, reduces difficulties with urine flow (e.g., weak stream), and limits sudden urgency to urinate and frequent urination.

Form: capsules, extended release, hard

ATC: G04CA02

Manufacturer: APL Swift Services (Malta) Ltd., Generis Farmaceutica S.A.

The medicine is used in men to treat symptoms related to benign prostatic hyperplasia. It helps facilitate urination, reduces bladder urgency, and improves urinary flow.

Form: capsules, hard modified release

ATC: G04CA02

Manufacturer: Laboratorios Liconsa S.A.

This medicine is used to relieve urinary symptoms caused by benign prostatic hyperplasia. It relaxes the muscles of the urinary tract and the prostate, which makes urination easier.

Form: capsules, hard modified release

ATC: G04CA02

Manufacturer: Medis International a.s., Pharmazet Group s.r.o., Synthon B.V., Synthon Hispania S.L.

The medicine is used to treat symptoms associated with benign prostatic hyperplasia. It helps facilitate urination, reduces a weak urinary stream, urgency, and frequent urination during the day and night.

Form: tablets, prolonged release

ATC: G04CA02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

It is used in men to relieve moderate or severe symptoms related to urination and bladder storage, caused by bladder problems and prostate enlargement (benign prostatic hyperplasia).

Form: tablets, modified release

ATC: G04CA53

Manufacturer: Adamed Pharma S.A.

The medicine is used to relieve urinary symptoms caused by an enlarged prostate (benign prostatic hyperplasia). It works by relaxing the muscles, which facilitates urination.

Form: capsules, hard modified release

ATC: G04CA02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used to treat symptoms related to benign prostatic hyperplasia (enlarged prostate). It helps facilitate urination when there are difficulties starting to urinate, frequent urgency (including at night), or a sensation of incomplete bladder emptying.

Form: capsules, modified release

ATC: G04CA02

Manufacturer: Krka, d.d., Novo mesto

It is used in men to relieve symptoms associated with benign prostatic hyperplasia. It helps facilitate urination, reduces weak urinary stream, urgency, and frequent urination during the day and night.

Form: tablets, prolonged release

ATC: G04CA02

Manufacturer: Krka, d.d., Novo mesto

The medicine is used to treat symptoms related to mild enlargement of the prostate gland. It helps facilitate urination, reduces bladder urgency, and helps with a weak urinary stream or frequent urination.

Form: capsules, hard modified release

ATC: G04CA02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

It is used to treat symptoms associated with benign prostatic hyperplasia. It helps facilitate urination, reduces weak urinary stream, bladder urgency, and frequent urination during the day and night.

Form: tablets, prolonged release

ATC: G04CA02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used to relieve urinary tract symptoms caused by benign prostatic hyperplasia (enlarged prostate). It helps facilitate urine flow and voiding by relaxing the smooth muscles of the urinary tract and the prostate.

Form: capsules, hard modified release

ATC: G04CA02

Manufacturer: Lamp San Prospero S.p.A, STADA Arzneimittel AG